Skip to main content

Table 2 Comparison of effects of different intervention

From: Atorvastatin combined with poly-unsaturated fatty acid confers better improvement of dyslipidemia and endothelium function

Variables Sham (n = 10) Control (n = 10) Atorvastatin (n = 10) PUFA (n = 10) Combined (n = 10)
TG (mmol/L) 1.07 ± 0.09 1.26 ± 0.14 1.18 ± 0.12 1.20 ± 0.17 1.11 ± 0.08#
TC (mmol/L) 3.84 ± 0.15 4.32 ± 0.11 4.16 ± 0.16 4.18 ± 0.13 4.06 ± 0.06#
LDL-C (mmol/L) 2.02 ± 0.11 2.33 ± 0.20 2.17 ± 0.25 2.19 ± 0.17 2.10 ± 0.12#
HDL-C (mmol/L) 0.92 ± 0.03 0.91 ± 0.03 0.92 ± 0.04 0.95 ± 0.06 1.01 ± 0.03#
NO (μmol/L) 12.18 ± 1.16 9.02 ± 1.00 10.27 ± 1.14 10.14 ± 1.08 10.88 ± 1.04#
CRP (mg/L) 2.10 ± 0.39 4.68 ± 0.37 3.67 ± 0.42 3.72 ± 0.33 3.28 ± 0.30#
sVCAM (μg/mL) 3.48 ± 0.22 4.98 ± 0.24 4.46 ± 0.53 4.49 ± 0.27 4.17 ± 0.38#
sICAM (μg/mL) 0.40 ± 0.04 0.58 ± 0.05 0.53 ± 0.03 0.53 ± 0.04 0.49 ± 0.04#
MDA (nmol/L) 0.82 ± 0.06 1.10 ± 0.08 1.02 ± 0.03 1.03 ± 0.03 0.96 ± 0.05#
  1. Denote: #p < 0.05 versus control group.